ArticleOncology reports2020

FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.

Rongrong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.